Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 40% ± 22% | |
eye | 8 studies | 23% ± 10% | |
lung | 6 studies | 23% ± 5% | |
peripheral blood | 4 studies | 26% ± 7% | |
liver | 4 studies | 26% ± 11% | |
adipose | 4 studies | 21% ± 4% | |
pancreas | 3 studies | 38% ± 15% | |
placenta | 3 studies | 22% ± 3% | |
heart | 3 studies | 21% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3191.85 | 1445 / 1445 | 100% | 32.93 | 183 / 183 |
ovary | 100% | 2906.94 | 180 / 180 | 100% | 17.73 | 430 / 430 |
brain | 100% | 2760.06 | 2641 / 2642 | 100% | 23.09 | 705 / 705 |
breast | 100% | 2918.83 | 459 / 459 | 100% | 30.55 | 1117 / 1118 |
lung | 100% | 2631.18 | 577 / 578 | 100% | 23.84 | 1155 / 1155 |
prostate | 100% | 3015.11 | 245 / 245 | 100% | 23.37 | 501 / 502 |
bladder | 100% | 3592.90 | 21 / 21 | 99% | 19.90 | 500 / 504 |
thymus | 100% | 3739.66 | 653 / 653 | 99% | 28.49 | 600 / 605 |
pancreas | 100% | 3870.10 | 328 / 328 | 99% | 20.45 | 176 / 178 |
uterus | 100% | 4157.15 | 170 / 170 | 99% | 20.42 | 453 / 459 |
stomach | 100% | 2562.33 | 359 / 359 | 98% | 21.50 | 279 / 286 |
intestine | 100% | 3227.76 | 966 / 966 | 98% | 17.36 | 514 / 527 |
kidney | 100% | 1974.81 | 89 / 89 | 97% | 19.94 | 878 / 901 |
liver | 100% | 2369.65 | 226 / 226 | 96% | 14.20 | 391 / 406 |
adrenal gland | 100% | 2716.98 | 258 / 258 | 94% | 15.11 | 216 / 230 |
skin | 100% | 3120.49 | 1806 / 1809 | 93% | 20.11 | 437 / 472 |
blood vessel | 100% | 3842.59 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 2422.19 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 21.85 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 15.76 | 1 / 1 |
adipose | 100% | 3159.66 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 1920.94 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 1876.77 | 837 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 10.75 | 26 / 29 |
peripheral blood | 65% | 1146.16 | 603 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 50% | 4.25 | 40 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_1904382 | Biological process | mannose trimming involved in glycoprotein ERAD pathway |
GO_0048286 | Biological process | lung alveolus development |
GO_0006491 | Biological process | N-glycan processing |
GO_0006486 | Biological process | protein glycosylation |
GO_0007585 | Biological process | respiratory gaseous exchange by respiratory system |
GO_0000139 | Cellular component | Golgi membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0016020 | Cellular component | membrane |
GO_0004571 | Molecular function | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity |
GO_0005509 | Molecular function | calcium ion binding |
Gene name | MAN1A2 |
Protein name | alpha-1,2-Mannosidase (EC 3.2.1.-) Mannosidase alpha class 1A member 2 Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (EC 3.2.1.113) (Mannosidase alpha class 1A member 2) (Processing alpha-1,2-mannosidase IB) (Alpha-1,2-mannosidase IB) |
Synonyms | MAN1B |
Description | FUNCTION: Involved in the maturation of Asn-linked oligosaccharides. Progressively trim alpha-1,2-linked mannose residues from Man(9)GlcNAc(2) to produce Man(5)GlcNAc(2). |
Accessions | H0Y543 ENST00000421535.5 O60476 ENST00000356554.7 ENST00000449370.6 ENST00000422329.1 H0Y7H1 Q5T9E3 |